Results for this period
Third quarter1 October 2025 to 30 June 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Net sales increased by ¥53 million year on year. In the Financial Solutions business, revenue from commissioned development projects and license fees increased, while losses in the Business Solutions business improved due to lower personnel expenses. In contrast, the Healthcare business reported lower revenue and wider losses because sales of the “IT Hanabiratake” product were delayed. Although the company incurred a ¥133 million equity-method investment loss, net income turned profitable due to a ¥230 million gain on change in equity interest.
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 October 2025 to 30 June 2026 |
| Net Sales | ¥1,336 million (YoY +4.2%) |
| Operating profit | ¥22 million |
| Ordinary income | ¥-111 million |
| Profit attributable to owners of the parent | ¥104 million |
| Net income per share | ¥14.56 |
| Equity ratio | End of the current fiscal period 77.4 / End of previous period 72.6 |
| Total assets | ¥1,524 million |
| Net assets | ¥1,180 million |
| Full-year earnings forecast | Net Sales ¥1,836 million (YoY -0.0%) / Operating profit ¥30 million / Ordinary income ¥-142 million / Net income ¥78 million |
| Revision to Earnings Forecast | Not disclosed → Net Sales ¥1,836 million / Operating profit ¥30 million / Ordinary income ¥-142 million / Net income ¥78 million |
| Annual Dividend Forecast | 0 yen and sen → 0 yen and sen |
| Segment revenue | Financial Solutions Business ¥1,088 million (YoY +107.6%), Business Solutions business ¥174 million (YoY +90.9%), Healthcare Business ¥73 million (YoY +92.9%) |
| Segment profit | Financial Solutions Business ¥330 million (YoY +111.5%), Business Solutions business ¥-12 million, Healthcare Business ¥-46 million |
| Depreciation and amortization | ¥13,058 thousand |
| Impairment loss | Not applicable (impairment losses on fixed assets by reporting segment) |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on changes in equity interests ¥230,114 thousand, Reversal of retirement benefit provision ¥3,713 thousand / Extraordinary loss No applicable matters. |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 0 / Company name None / Excluded Number of companies 0 / Company name None |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | None (対象者：Not disclosed) |
| Issued Shares at Period-End | 7,444,800 |
| Treasury Shares at Period-End | 259,250 |
| Factors Behind Changes in Business Performance | Net sales increased by ¥53 million year on year. In the Financial Solutions business, revenue from commissioned development projects and license fees increased, while losses in the Business Solutions business improved due to lower personnel expenses. In contrast, the Healthcare business reported lower revenue and wider losses because sales of the “IT Hanabiratake” product were delayed. Although the company incurred a ¥133 million equity-method investment loss, net income turned profitable due to a ¥230 million gain on change in equity interest. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Financial Solutions business, revenue from commissioned development projects and license fees increased. Losses in the Business Solutions business improved due to lower personnel expenses, while the Healthcare business reported lower revenue and wider losses because sales of the “IT Hanabiratake” product were delayed compared with the plan. Although the company recorded a ¥133 million equity-method investment loss, net income improved because it recognized a ¥230 million gain on change in equity interest associated with Digital Asset Markets’ capital increase.